Our Purpose
Animalcare Group plc is an international, development focused sales and marketing organisation driven by a collective belief that healthy animals can have a hugely beneficial effect on their owners and wider society




JAN BOONE
Non-Executive Chair
Animalcare’s performance in 2022 highlighted the resilience of our business and of the animal health markets in which we operate
Our Strategy
We are pursuing our strategic ambition of becoming a leading player in all our markets. In 2022 we continued to focus on the five pillars of our growth strategy.

DELIVERING ON OUR STRATEGY
Orthros Medical
In March 2022 we took a major step forward in the development of our longer-term pipeline through a collaboration and licensing deal with Orthros Medical, a Netherlands-based company focused on novel VHH antibody technology.
We are delighted with how the relationship with Orthros Medical is working and the progress made in the initial phase of the collaboration. One year into our agreement, it’s clear that supporting earlier stage research in tandem with experts in the field fits our model well and provides an opportunity to develop innovative products that can deliver sustainable future growth.

Derived from llamas, VHH antibodies have been shown to possess a number of clinical uses.



WHY ANIMALCARE?

OUR STRATEGIC PRIORITIES
We are pursuing our strategic ambition of becoming a leading player in all our markets. In 2022 we continued to focus on the five pillars of our growth strategy.
Strong finances
Key leadership
Growth portfolio
Business development
Innovative pipeline
Strong finances
Key leadership
Growth portfolio
Business development
Innovative pipeline


